AI assistant
Pfizer Ltd. — Board/Management Information 2024
Jan 22, 2024
60507_rns_2024-01-22_5d6ce41a-724c-4656-9fd4-506bbd0268bb.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [100 x 41] intentionally omitted <==
Pfizer Limited
The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
January 22, 2024
The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER
Dear Sirs,
Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure − Requirements) Regulations, 2015 Appointment of Mr. Amit Agarwal as Executive Director – Finance & Chief Financial Officer of Pfizer Limited.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that upon recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today appointed Mr. Amit Agarwal as the Chief Financial Officer of the Company effective February 26, 2024.
Further, upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today, also appointed Mr. Amit Agarwal (DIN: 10465938) as an Additional Director (Whole-time Director) of the Company, designated as Executive Director – Finance & Chief Financial Officer for a period of 5 years with effect from February 26, 2024. The said appointment shall be subject to the approval of shareholders.
Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A.
Request you to please take the above on record.
Thanking you,
Yours truly,
For Pfizer Limited PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.01.22 08:32:22 +05'30' Prajeet Nair
Director – Corporate Services & Company Secretary
CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in
ANNEXURE A
Information as required under Regulation 30 - Part A of Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
| Sr.no. | Particulars | Details |
|---|---|---|
| 1. | Reasons for change | Fresh Appointment |
| 2. | Date of Appointment and Term | Appointed as the Chief Financial Officer of theCompany effective February 26, 2024.AlsoappointedasanAdditionalDirector(Whole-time Director), designated as ExecutiveDirector – Finance & Chief Financial Officer effectiveFebruary 26, 2024 for a period of 5 (Five) years. |
| 3. | Affirmation as per List/Comp/14/2018-19 dated June 20, 2018 | We hereby affirm that Mr. Amit Agarwal is notdebarred or disqualified from holding the office ofDirector by virtue of any order from MCA/SEBI or anyother such statutory authority. |
| 4. | RelationshipInter-seDirectors/Key Managerial Personnel | Mr. Amit Agarwal is not related to any of theDirectors/KeyManagerialPersonneloftheCompany. |
| 5. | Number of Shares held in theCompany | Nil |
| 6. | Brief Profile | Mr. Amit Agarwal is a seasoned Finance Professionaland brings with him solid experience of 20 yearsacross a wide spectrum of Finance functionsincluding Accounting, Reporting, Audit, Controls,Strategy and Change management, gained acrossdiverse industries such as Consumer, Services andMining.Mr. Agarwal joins us from India’s largest consumercompany, Hindustan Unilever Limited, where hespent the last 17 years serving in various rolesincluding Accounting, Auditing and controllership aswell as Business Finance roles for different BusinessUnits including Bakery, Tea, Hair, Deodorants &Professional Products. In his current assignment atHindustan Unilever Limited (HUL), Mr. Agarwal is theGeneral Manager, Finance, handling the function forthe Sales and Customer Development vertical.Mr. Agarwal also has a significant experience inleading global teams. As the Financial Controller forGlobal Business Services (GBS), he has led anEnd-to-End (E2E) controllership working with ageographically diverse team across India, UK,Philippines, and Brazil. Prior to joining HUL, early partofMr.Agarwal’scareerwaswithVedantaResourcesLimited,India’slargestdiversified natural resources company as a FinancialPlanning&AnalysisManagerandFactoryCommercial Manager.Mr. Amit Agarwal is a Chartered Accountant,a Cost Accountant and a Company Secretary.Mr. Agarwal’s stellar academic record mirrors hissolid foundation in financial management and hisstrong career trajectory.Mr. Amit Agarwal does not hold directorship in anyother company. |